Sex Disparities in Hypoxic Sympatholysis and Impact of Obesity

EARLY_PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

December 9, 2020

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
ObesityHealthyVasoconstrictionVasodilation
Interventions
OTHER

Hypoxia Exposure

Systemic oxygen levels will be titrated to attain hypoxemia as assessed by pulse oximetry.

DRUG

Phenylephrine

Phenylephrine (0.0625 mcg/dL/min) will be locally infused via brachial artery catheter during the final 3 min of normoxia and hypoxia.

DRUG

Dexmedetomidine

Dexmedetomidine (12.5 ng/dL/min) will be locally infused via brachial artery catheter during the final 3 min of normoxia and hypoxia.

DRUG

Phentolamine

Phentolamine will be locally infused via brachial artery catheter for 10 min before baseline measurement (12 mcg/dL/min) and the infusion will continue at a maintenance rate (5 mcg/dL/min) during acute normoxia and hypoxia.

DRUG

Norepinephrine

Regional forearm infusion at 8 ng/dL/min via brachial artery catheter during normoxia and hypoxia exposures

Trial Locations (1)

65211

University of Missouri-Columbia, Columbia

All Listed Sponsors
lead

University of Missouri-Columbia

OTHER